In this episode of Milk Road Stocks, ARK Invest Chief Futurist Brett Winton and Multi-Omics Portfolio Manager Ovid Amadi explain why the convergence of artificial intelligence, genomics, gene editing, cancer diagnostics, and drug discovery could create one of the biggest investment opportunities of the AI era. The core idea: biology is generating enormous amounts of proprietary data, and AI is becoming powerful enough to turn that data into better drugs, earlier diagnoses, personalized cancer treatments, and potentially one-time genetic therapies.
~~~~
~~~~~
🚀 Trade, earn, and borrow in one place with Nexo, a trusted digital asset platform managing over $7B in assets:
~~~~~
✊ Follow Milk Road on Social Media:
👉 YouTube: https://www.youtube.com/@MilkRoadStocks
~~~~~
🎙 GUEST INFO 🎙
Ovid Amadi: https://x.com/Ovid_ARK
Brett Winton: https://x.com/wintonARK
📃 Disclaimer 📃
The information presented in this video is for educational and informational purposes only. It should not be considered as financial, legal, or tax advice. The speakers are not licensed financial advisors or registered investment advisors. Investing in cryptocurrencies carries significant risks, including the potential for substantial losses. The speakers do not guarantee any specific outcome or profit.